Clinical Trials in Atlanta

Showing 16901-16920 of 19,805 trials

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

NCT01258387

Study to determine the safety, tolerability, pharmacokinetics and immunogenicity of single intravenous administrations of GGF2 in patients with heart failure.

Heart Failure

Acorda Therapeutics40 participantsStarted Dec 2010

Atlanta, Georgia, United States • Nashville, Tennessee, United States

COMPLETEDNA< 1 mile

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

NCT01146782

This is a prospective study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea. The objective of the study is to demonstrate safety and effectiveness of the Attune Sleep Apnea System to support FDA marketing clearance of the device.

Obstructive Sleep Apnea

ApniCure, Inc.367 participantsStarted Jun 2010

Phoenix, Arizona, United States • Burlingame, California, United States • Menlo Park, California, United States +3 more locations

WITHDRAWNPhase 3< 1 mile

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

NCT00874302

Subjects with symptomatic uterine fibroids will be enrolled and will receive daily oral study medication for 4 months. This will be followed by a 6 month off-drug interval until there is a return of significant symptomatology. If they experience symptoms of a certain severity, the subject will enter a second 4 month treatment cycle and then a follow-up period.

Uterine Fibroids

Repros Therapeutics Inc.

San Diego, California, United States • Sarasota, Florida, United States • Atlanta, Georgia, United States +17 more locations

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Find Trials by Condition in Atlanta

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Citalopram for Agitation in Alzheimer's Disease

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I